Mount Sinai Hospital

Mount Sinai Hospital, a New York City-based tax-exempt nonprofit hospital, operates as a federal grant recipient and prime contractor delivering specialized clinical services and behavioral health research programs to the Department of Veterans Affairs, the Department of Justice, and the Department of Health and Human Services, with mixed footprint across direct prime grant awards (44% of recent federal awards) and sub-recipient roles under state and federal grants (56%).

Mount Sinai's federal footprint is dominated by grant work rather than contracts. The hospital holds three prime project grants from the Department of Justice Office for Victims of Crime (CFDA 16.582 and CFDA 16.320): a $500,000 award effective October 2025 through September 2028 to expand healthcare and support services for young crime victims through the Mount Sinai Adolescent Health Center in East Harlem, including screening for victimization, case management led by licensed clinical social workers, dental care, and optical services; an $800,000 award from October 2024 through September 2027 to increase behavioral health services for human trafficking victims aged 10–26 by training clinicians in Cognitive Processing Therapy and implementing CPT services in primary care and mental health clinics; and a prior award from October 2022 through September 2025 to create an autonomous program for youth trafficking victims providing primary, mental, sexual and reproductive, and optical care to 100 survivors per year in coordination with Covenant House NY, Strive, and Sanctuary for Families. On the contract side, Mount Sinai holds three small delivery orders with the Department of Veterans Affairs Veterans Integrated Service Network 2 and VISN 22 totaling approximately $96,272 for neuromuscular biopsy services at the Northport VA Medical Center, with one delivery order exercising an option year through December 2025 and a definitive contract valued at $84,845 for education in geriatrics and gerontology awarded in September 2022.

Customer concentration by award count is split between high-volume grant work and smaller contract programs. The Federal Emergency Management Agency Headquarters Financial Assistance Awards program accounts for 23 awards (the single largest customer by count); the Department of Veterans Affairs Veterans Health Administration VISN 2 placed 9 awards; and the Department of Justice Office of Justice Programs Victims of Crime issued 5 awards. However, the top customers by potential value diverge: the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response leads with $1.4 million combined potential value across 4 awards, followed by VA VISN 2 with $279 thousand across 9 awards. Mount Sinai sits on at least four indefinite delivery contracts for VA neuromuscular biopsy services and related clinical work, with the largest (IDC 36C24221D0048) carrying 3 task orders valued at $79 thousand combined.

In its sub-recipient role, Mount Sinai participates in federal grants administered through New York State agencies. The hospital is a sub-recipient under New York State Division of Homeland Security & Emergency Services grants (multiple awards for pandemic response costs, facilities, and staffing through June 2023); New York State Office of Mental Health grants supporting the On-Track New York program for youth experiencing first episodes of psychosis (multiple sub-awards from December 2023 through March 2026); Public Health Solutions grants including the Hospital Preparedness Program (sub-awards with combined amendments totaling approximately $577,500); Weill Medical College of Cornell University (a sub-award under which Mount Sinai clinicians including Dr. James Murrough and Dr. Helen Mayberg conduct clinical trials on ketamine and transcranial magnetic stimulation for treatment-resistant depression); and New York State Office of Victim Services (Victim Assistance Program sub-awards from October 2024 and October 2025). Award activity has fluctuated—six awards in 2022, one in 2023, eleven in 2024, six in 2025, and five through March 2026—with only one award reaching ultimate completion within the next twenty-four months.